Management of Migraine Pain: Emerging Opportunities and Challenges

Dr. Shvetank Bhatt is currently working as an associate professor in School of Health Sciences and Technology, Dr. Vishwanath Karad MIT World Peace University, Pune, Maharashtra, India. He has done M.Pharm in pharmacology from Manipal College of Pharmaceutical Sciences, MAHE, Manipal, Karnataka and Ph.D. in Neuropharmacology from Birla Institute of Technology & Science (BITS) Pilani, Pilani Campus, Rajasthan. He has total 16 years of industrial and academic research experience. His area of specialization is CNS disorders, pain, inflammation and immunooncology. He is recipient of Prof. Duggirala Visweswaram & Prof. Sreemantalu Satyanarayana Award (Best Paper in Pharmacology-IJPER) in 2012 and 2014. He has published more than 80 papers and 20 book chapters. Dr. Bhatt is having total citation 1445; h- index 18 and i10- index 42. He is life member of Association of Pharmaceutical Teachers of India (APTI) and Indian Pharmacological Society (IPS).

Prof. (Dr.) CR Patil is working as a professor and head, Dept. of Pharmacology, R. C Patel Institute of Pharmaceutical Education and Research, Shirpur, Maharashtra. He has done M.Pharm in pharmacology from Gujarat University, Ahmedabad and PhD from Shivaji University Kolhapur. He has more than 24 years of teaching and research experience. His area of expertise is CVS Pharmacology, pain and inflammation. He is recipient of various awards including Innovator Teacher Award (2017), MHRD, Govt of India, New Delhi and Young Scientist Award (2017), CCRH-AYUSH, New Delhi. He has published more than 100 papers and book chapters. Dr. Patil is having total citation 4200; h- index 34 and i10- index 66.

Prof. (Dr.) Neeraj Mahindroo is medicinal chemist with experience of over 25 years in academics and research. Currently he is working as professor and dean at School of Health Sciences and Technology, MIT World Peace University, Pune, India. Earlier he was founder Dean of the School of Health Sciences and Technology, UPES, Dehradun. He was also the Dean of the Faculty of Pharmaceutical Sciences and Dean of Research & Development at Shoolini University. School of Pharmaceutical Sciences was ranked in the top 40 under the leadership for four consecutive years (2016 (19), 2017(39), 2018 (30), 2019 (39)) by the National Institutional Ranking Framework (NIRF), Ministry of HRD, Government of India. Member of University NIRF, NAAC, and NBA core team.

Experience in PCI and AICTE fillings and inspections. His research interests are drug discovery for neglected diseases, neurological disorders, and cancer, screening of fractionated extracts, and isolated compounds from plants from the North-Western Himalayas. Published 45 papers with more than 2194 citations (h index = 25; i10 index=36), five patents, and ten patent applications. He is Member of the Editorial Advisory Board of ACS Medicinal Chemistry Letters and member of CII National Committee on R&D & Innovation 2020-21, part of the Sub-group on Healthcare & Chemicals.

Dr. Shvetank Bhatt 目前擔任印度馬哈拉施特拉邦浦那市 Dr. Vishwanath Karad MIT 世界和平大學健康科學與技術學院的副教授。他在卡納塔克邦的 Manipal College of Pharmaceutical Sciences 獲得藥理學碩士學位，並在拉賈斯坦邦的 Birla Institute of Technology & Science (BITS) Pilani 獲得神經藥理學博士學位。他擁有總共 16 年的產業和學術研究經驗，專長於中樞神經系統疾病、疼痛、發炎和免疫腫瘤學。他曾於 2012 年和 2014 年獲得 Prof. Duggirala Visweswaram 和 Prof. Sreemantalu Satyanarayana 獎（最佳藥理學論文-IJPER）。他已發表超過 80 篇論文和 20 篇書章。Dr. Bhatt 的總引用次數為 1445；h 指數 18，i10 指數 42。他是印度藥學教師協會 (APTI) 和印度藥理學會 (IPS) 的終身會員。

Prof. (Dr.) CR Patil 擔任 R. C Patel Institute of Pharmaceutical Education and Research 藥理學系的教授及系主任，位於印度馬哈拉施特拉邦的 Shirpur。他在古吉拉特邦的古吉拉特大學獲得藥理學碩士學位，並在科爾哈普爾的 Shivaji University 獲得博士學位。他擁有超過 24 年的教學和研究經驗，專長於心血管藥理學、疼痛和發炎。他曾獲得多項獎項，包括 2017 年的創新教師獎（MHRD，印度政府，新德里）和 2017 年的青年科學家獎（CCRH-AYUSH，新德里）。他已發表超過 100 篇論文和書章。Dr. Patil 的總引用次數為 4200；h 指數 34，i10 指數 66。

Prof. (Dr.) Neeraj Mahindroo 是一位藥物化學家，擁有超過 25 年的學術和研究經驗。目前他擔任印度浦那市 MIT 世界和平大學健康科學與技術學院的教授及院長。之前，他是 UPES（德拉敦）的健康科學與技術學院的創院院長。他還曾擔任 Shoolini University 藥學院的院長及研究與發展院長。在他的領導下，藥學院在印度人力資源部的國家機構排名框架 (NIRF) 中連續四年（2016 年 (19)、2017 年 (39)、2018 年 (30)、2019 年 (39)）排名前 40 名。他是大學 NIRF、NAAC 和 NBA 核心團隊的成員。

他在 PCI 和 AICTE 的申請及檢查方面有經驗。他的研究興趣包括針對被忽視疾病、神經系統疾病和癌症的藥物發現，篩選來自西北喜馬拉雅山的植物的分離提取物和化合物。他已發表 45 篇論文，引用次數超過 2194 次（h 指數 = 25；i10 指數 = 36），擁有五項專利和十項專利申請。他是 ACS Medicinal Chemistry Letters 編輯諮詢委員會的成員，並且是 CII 2020-21 年度 R&D 和創新國家委員會的成員，參與醫療保健與化學的子小組。